You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 9, September 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical and Genetic Analysis of Progressive Dystonia With Diurnal Variation

John K. Fink, MD; Paula D. Ravin, MD; Michelle Filling-Katz, MD; Charles E. Argoff, MD; Mark Hallett, MD

Arch Neurol. 1991;48(9):908-911.


Abstract

• We examined 17 patients with progressive dystonia with diurnal variation, a dominantly inherited, generalized dystonia that begins in childhood. Dystonia was typically least severe in the morning, increased as the day continued, and markedly improved with low doses of carbidopa-levodopa. We also studied the patient's parents, children, and siblings from seven families. We observed a spectrum of neurologic involvement, phenotypic variability among siblings, and incomplete genetic penetrance. Progression of motor impairment over several years, which reaches a plateau during late adolescence, is useful in distinguishing progressive dystonia with diurnal variation from cerebral palsy and degenerative disorders. It is important to recognize the subtle, as well the extreme, manifestations of progressive dystonia with diurnal variation because it is treatable. Genetic counseling must consider that mildly affected parents with little or no disability may have profoundly affected children. Appreciation of the phenotypic variability and degree of genetic penetrance will permit detailed genetic and biochemical analyses.



Author Affiliations

From the Department of Neurology, University of Michigan, Ann Arbor (Dr Fink); the Developmental and Metabolic Neurology Branch (Drs Filling-Katz and Argoff) and the Medical Neurology Branch (Dr Hallett), National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda Md; and the Department of Neurology, University of Massachusetts, Worcester (Dr Ravin).


Footnotes

Accepted for publication March 12, 1991.

Reprint requests to 1120-A Neuroscience Laboratory, Department of Neurology, University of Michigan, 1103 E Huron St, Ann Arbor, MI 48104-1687 (Dr Fink).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients
Trender-Gerhard et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:839-845.
ABSTRACT | FULL TEXT  

Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture?
Grimes et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:801-804.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.